Please use this identifier to cite or link to this item:
|Title:||Patents in the Life Sciences|
|Abstract:||The paper discusses the issue of gene patenting, a subject of considerable international public and media attention. Some groups have raised the issue whether it is appropriate to have patents in the field of biotechnology and others support the idea of patenting in principle, but are concerned about the effect of patents on the continuing research efforts and the cost of new medicines and diagnostics. The author further discusses about the importance of patents in biotechnology specifically for small and medium entrepreneurs because they invest substantially in R&D to bring new products to the market. There is also a brief discussion about the European Union Directive, new US patent and trademark guidelines focusing on the utility requirement of the patent statute, on-going ethical reviews and ethical issues. In the end, the author discusses about the supportive approach of BioIndustry Association to the development of biotechnology industry, which promotes research into new knowledge and new benefits for the society.|
|ISSN:||0975-1076 (Online); 0971-7544 (Print)|
|Appears in Collections:||JIPR Vol.06(6) [November 2001]|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.